Selective up-regulation of arginase-1 in coronary arteries of diabetic patients

Zsolt Bagi, Attila Feher, Huijuan Dou, Zuzana Broskova

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Coronary artery disease (CAD) remains the leading cause of death in the Western societies. Diabetes mellitus (DM) is one of the highly prevalent diseases, which remarkably accelerates the development of CAD. Experimental evidence indicates that decreased bioavailability of coronary endothelial nitric oxide (NO) contributes to the development of CAD in DM. There are recent studies showing that a selective impairment of NO synthesis occurs in coronary arteries of DM patients, which is mainly due to the limited availability of endothelial NO synthase (eNOS) precursor, L-arginine. Importantly, these studies demonstrated that DM, independent of the presence of CAD, leads to selective up-regulation of arginase-1. Arginase-1 seems to play an important role in limiting l-arginine availability in the close proximity of eNOS in vessels of DM patients. This brief review examines recent clinical studies demonstrating the pathological role of vascular arginase-1 in human diabetes. Whether arginase-1, which is crucial in the synthesis of various fundamental polyamines in the body, will represent a potent therapeutic target for prevention of DM-associated CAD is still debated.

Original languageEnglish (US)
Article numberArticle 293
JournalFrontiers in Immunology
Volume4
Issue numberSEP
DOIs
StatePublished - Oct 28 2013

Fingerprint

Arginase
Coronary Vessels
Diabetes Mellitus
Up-Regulation
Coronary Artery Disease
Arginine
Nitric Oxide
Nitric Oxide Synthase Type III
Polyamines
Nitric Oxide Synthase
Biological Availability
Blood Vessels
Cause of Death

Keywords

  • Arginase
  • Coronary artery
  • Diabetes mellitus
  • Endothelium
  • Nitric oxide

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Selective up-regulation of arginase-1 in coronary arteries of diabetic patients. / Bagi, Zsolt; Feher, Attila; Dou, Huijuan; Broskova, Zuzana.

In: Frontiers in Immunology, Vol. 4, No. SEP, Article 293, 28.10.2013.

Research output: Contribution to journalReview article

Bagi, Zsolt ; Feher, Attila ; Dou, Huijuan ; Broskova, Zuzana. / Selective up-regulation of arginase-1 in coronary arteries of diabetic patients. In: Frontiers in Immunology. 2013 ; Vol. 4, No. SEP.
@article{9f33cac8f872422db3e58540910165c5,
title = "Selective up-regulation of arginase-1 in coronary arteries of diabetic patients",
abstract = "Coronary artery disease (CAD) remains the leading cause of death in the Western societies. Diabetes mellitus (DM) is one of the highly prevalent diseases, which remarkably accelerates the development of CAD. Experimental evidence indicates that decreased bioavailability of coronary endothelial nitric oxide (NO) contributes to the development of CAD in DM. There are recent studies showing that a selective impairment of NO synthesis occurs in coronary arteries of DM patients, which is mainly due to the limited availability of endothelial NO synthase (eNOS) precursor, L-arginine. Importantly, these studies demonstrated that DM, independent of the presence of CAD, leads to selective up-regulation of arginase-1. Arginase-1 seems to play an important role in limiting l-arginine availability in the close proximity of eNOS in vessels of DM patients. This brief review examines recent clinical studies demonstrating the pathological role of vascular arginase-1 in human diabetes. Whether arginase-1, which is crucial in the synthesis of various fundamental polyamines in the body, will represent a potent therapeutic target for prevention of DM-associated CAD is still debated.",
keywords = "Arginase, Coronary artery, Diabetes mellitus, Endothelium, Nitric oxide",
author = "Zsolt Bagi and Attila Feher and Huijuan Dou and Zuzana Broskova",
year = "2013",
month = "10",
day = "28",
doi = "10.3389/fimmu.2013.00293",
language = "English (US)",
volume = "4",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Selective up-regulation of arginase-1 in coronary arteries of diabetic patients

AU - Bagi, Zsolt

AU - Feher, Attila

AU - Dou, Huijuan

AU - Broskova, Zuzana

PY - 2013/10/28

Y1 - 2013/10/28

N2 - Coronary artery disease (CAD) remains the leading cause of death in the Western societies. Diabetes mellitus (DM) is one of the highly prevalent diseases, which remarkably accelerates the development of CAD. Experimental evidence indicates that decreased bioavailability of coronary endothelial nitric oxide (NO) contributes to the development of CAD in DM. There are recent studies showing that a selective impairment of NO synthesis occurs in coronary arteries of DM patients, which is mainly due to the limited availability of endothelial NO synthase (eNOS) precursor, L-arginine. Importantly, these studies demonstrated that DM, independent of the presence of CAD, leads to selective up-regulation of arginase-1. Arginase-1 seems to play an important role in limiting l-arginine availability in the close proximity of eNOS in vessels of DM patients. This brief review examines recent clinical studies demonstrating the pathological role of vascular arginase-1 in human diabetes. Whether arginase-1, which is crucial in the synthesis of various fundamental polyamines in the body, will represent a potent therapeutic target for prevention of DM-associated CAD is still debated.

AB - Coronary artery disease (CAD) remains the leading cause of death in the Western societies. Diabetes mellitus (DM) is one of the highly prevalent diseases, which remarkably accelerates the development of CAD. Experimental evidence indicates that decreased bioavailability of coronary endothelial nitric oxide (NO) contributes to the development of CAD in DM. There are recent studies showing that a selective impairment of NO synthesis occurs in coronary arteries of DM patients, which is mainly due to the limited availability of endothelial NO synthase (eNOS) precursor, L-arginine. Importantly, these studies demonstrated that DM, independent of the presence of CAD, leads to selective up-regulation of arginase-1. Arginase-1 seems to play an important role in limiting l-arginine availability in the close proximity of eNOS in vessels of DM patients. This brief review examines recent clinical studies demonstrating the pathological role of vascular arginase-1 in human diabetes. Whether arginase-1, which is crucial in the synthesis of various fundamental polyamines in the body, will represent a potent therapeutic target for prevention of DM-associated CAD is still debated.

KW - Arginase

KW - Coronary artery

KW - Diabetes mellitus

KW - Endothelium

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=84885982946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885982946&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2013.00293

DO - 10.3389/fimmu.2013.00293

M3 - Review article

VL - 4

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - SEP

M1 - Article 293

ER -